Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Fig. 1

a. Flow diagram of the study design with three arms A, B and C. Randomisation is between arm B and C in the deemed un-resectable cohort. b. Consort flow diagram of the study participants. A total of 18 patients assessed, 10 were excluded and 8 registered. Of the latter, 5 were randomised. c. Planned and actual recruitment during the study period

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us